Assignee
CUREVAC GMBH
DE9 patents
Top patents by PatentIndex Score
US9669089B2Jun 6, 2017
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC GMBH107 citations99
US9683233B2Jun 20, 2017
Artificial nucleic acid molecules for improved protein or peptide expression
CUREVAC GMBH61 citations98
US9447431B2Sep 20, 2016
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC GMBH70 citations98
US9616084B2Apr 11, 2017
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
CUREVAC GMBH68 citations97
US9155788B2Oct 13, 2015
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC GMBH64 citations96
US8383340B2Feb 26, 2013
Method for purifying RNA on a preparative scale by means of HPLC
CUREVAC GMBH164 citations96
US9890391B2Feb 13, 2018
RNA vector with an open reading frame, an albumin 3′-UTR, and a histone stem loop
CUREVAC GMBH30 citations94
US9314535B2Apr 19, 2016
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
CUREVAC GMBH32 citations94
US9352028B2May 31, 2016
Composition for treating lung cancer, particularly of non-small lung cancers (NSCLC)
CUREVAC GMBH33 citations90